Cannabis and Gun Rights: Federal Law, State Conflicts, and Legal Changes

Executive Summary

Federal restrictions barring cannabis users from firearm ownership face their most serious legal challenge in decades, with potential policy shifts emerging in 2026 that could reconcile Second Amendment rights with state-legal marijuana programs. For over 50 years, federal law has prohibited anyone who uses marijuana from purchasing or possessing firearms, creating a constitutional collision as 38 states have legalized medical cannabis and 24 have authorized adult-use programs. The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) enforces this ban through Form 4473, which requires gun purchasers to attest they are not "unlawful users" of controlled substances. Recent court decisions, regulatory reconsiderations, and legislative proposals now threaten to dismantle this framework. The stakes affect an estimated 55 million American cannabis consumers, firearms manufacturers facing market restrictions, state-legal operators navigating compliance, and civil liberties advocates challenging the constitutionalization of drug policy. This intersection of cannabis reform, gun rights, and federalism represents one of the most complex policy knots in American law.

Why This Matters

The cannabis-gun rights conflict affects constitutional protections, market access for tens of millions of Americans, and the viability of state-legal cannabis programs operating under federal prohibition. The scale of impact spans multiple stakeholder groups. Approximately 55 million Americans reported using cannabis in the past year according to the National Survey on Drug Use and Health, and roughly 40 percent of U.S. households contain at least one firearm. The overlap creates millions of individuals caught between state-legal activity and federal firearms restrictions. Medical cannabis patients face particularly acute dilemmas, forced to choose between doctor-recommended treatment and constitutional rights. State-legal cannabis operators confront operational security challenges. Federal law prohibits them from possessing firearms to protect cash-intensive businesses, even as banking restrictions force many to operate on a cash basis. This creates security vulnerabilities that have resulted in over 200 documented armed robberies of dispensaries between 2020 and 2025. The firearms industry loses access to a substantial consumer base. Market research estimates that removing the cannabis prohibition could expand the firearms market by 8-12 percent, representing $800 million to $1.2 billion in annual sales. Manufacturers and retailers in states with legal cannabis programs face reduced customer pools. Constitutional scholars view the conflict as a test case for fundamental rights analysis. The Supreme Court's 2022 decision in New York State Rifle & Pistol Association v. Bruen established a new framework requiring gun restrictions to align with historical tradition, creating uncertainty about whether drug-use-based prohibitions survive scrutiny. State governments invested billions in cannabis regulatory infrastructure face federal preemption questions. Twenty-four adult-use states have collectively issued over 15,000 dispensary licenses and collected $15.6 billion in tax revenue in 2025 alone. Federal firearms restrictions undermine state policy choices and create compliance confusion.

Background and History

The federal prohibition on firearm possession by cannabis users emerged from 1968 gun control legislation and hardened through decades of War on Drugs enforcement, creating a categorical ban that survived largely unchallenged until state-level legalization exposed its constitutional vulnerabilities.

The Gun Control Act of 1968

Congress passed the Gun Control Act of 1968 in response to the assassinations of President John F. Kennedy, Senator Robert Kennedy, and Dr. Martin Luther King Jr. The legislation, codified at 18 U.S.C. § 922(g), established nine categories of prohibited persons barred from possessing firearms. Subsection (g)(3) prohibited any person "who is an unlawful user of or addicted to any controlled substance" from receiving or possessing firearms. The statute did not define "unlawful user," leaving interpretation to regulatory agencies and courts. The Controlled Substances Act, passed in 1970, classified marijuana as a Schedule I controlled substance under 21 U.S.C. § 812, defining it as having no accepted medical use and high potential for abuse. This classification made any marijuana use "unlawful" under federal law, regardless of state legal status.

ATF Regulatory Framework Development

The ATF developed Form 4473, the Firearms Transaction Record, as the primary enforcement mechanism. The form requires prospective gun purchasers to answer whether they are "an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance." A "yes" answer disqualifies the purchaser. A false answer constitutes a felony under 18 U.S.C. § 922(a)(6), punishable by up to 10 years imprisonment. In 2011, as state medical cannabis programs expanded, the ATF issued an open letter clarifying that medical marijuana cardholders were prohibited persons. The September 21, 2011 guidance stated that "any person who uses or is addicted to marijuana, regardless of whether his or her State has passed legislation authorizing marijuana use for medicinal purposes, is an unlawful user of or addicted to a controlled substance, and is prohibited by Federal law from possessing firearms or ammunition."

State Legalization Creates Constitutional Collision

California became the first state to legalize medical cannabis with Proposition 215 in 1996. By 2012, when Colorado and Washington authorized adult-use sales, the disconnect between state law and federal firearms restrictions became acute. Colorado's Amendment 64, approved by voters in November 2012, legalized possession of up to one ounce of cannabis for adults 21 and older. Washington's Initiative 502 passed the same day with similar provisions. The Obama administration responded with the Cole Memorandum in August 2013, deprioritizing federal cannabis enforcement in states with robust regulatory systems. However, the memo explicitly did not address firearms restrictions, leaving the ATF prohibition in place even as state-legal markets expanded.

Early Legal Challenges Fail

The first major constitutional challenge reached the Ninth Circuit in 2016. In Wilson v. Lynch, plaintiff S. Rowan Wilson, a Nevada medical cannabis cardholder, sued after a firearms dealer refused to sell her a gun. Wilson argued the prohibition violated her Second Amendment rights. The Ninth Circuit upheld the ban on August 31, 2016, ruling that Congress had reasonably concluded that marijuana use "raises the risk of irrational or unpredictable behavior with which gun use should not be associated." The Supreme Court declined to hear Wilson's appeal in 2017, leaving the prohibition intact. Similar challenges in other circuits met the same fate through 2021, with courts applying intermediate scrutiny and deferring to congressional judgments about drug use and firearms safety.

The Bruen Decision Changes the Landscape

On June 23, 2022, the Supreme Court decided New York State Rifle & Pistol Association v. Bruen, fundamentally altering Second Amendment jurisprudence. Justice Clarence Thomas, writing for the 6-3 majority, rejected the two-step means-end scrutiny framework lower courts had used to evaluate gun restrictions. Instead, Bruen established that the government must demonstrate firearms regulations are "consistent with the Nation's historical tradition of firearm regulation." The decision required courts to identify historical analogues from the Founding era or Reconstruction period to justify modern gun restrictions. This originalist framework cast doubt on 20th-century prohibitions lacking clear historical precedent, including drug-use-based bans.

Post-Bruen Cannabis Cases Emerge

Within months of Bruen, defendants charged with violating 18 U.S.C. § 922(g)(3) began challenging the statute's constitutionality. The first major success came in United States v. Daniels, decided by the Fifth Circuit on August 9, 2023. The court held that the government failed to demonstrate a historical tradition of disarming citizens based on marijuana use, ruling that 922(g)(3) violated the Second Amendment as applied to Patrick Daniels, who was arrested for possessing firearms while using cannabis. Judge Jerry Smith wrote that the government "has not met its burden to justify an exception to the Second Amendment" for cannabis users. The decision created a circuit split, as other circuits had previously upheld the prohibition under pre-Bruen frameworks. On February 2, 2024, the Western District of Oklahoma ruled in United States v. Harrison that the historical record did not support disarming individuals based on cannabis use. Judge Patrick Wyrick wrote that "our history and tradition may support some limits on an intoxicated person's right to carry a weapon, but it does not support disarming a sober citizen based exclusively on his past drug usage."

The Hunter Biden Prosecution

The issue gained national attention through the prosecution of Hunter Biden, son of President Joe Biden. Biden was indicted in September 2023 for making false statements on Form 4473 by denying drug use while purchasing a firearm in October 2018. His defense team argued that 18 U.S.C. § 922(g)(3) was unconstitutional under Bruen. On June 11, 2024, a Delaware jury convicted Biden on three felony counts. However, his legal team continued to challenge the underlying statute's constitutionality on appeal, keeping the issue in the national spotlight and creating political pressure for reform.

DEA Rescheduling Proposal

On May 16, 2024, the Drug Enforcement Administration published a Notice of Proposed Rulemaking (NPRM) to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act. The proposal followed a recommendation from the Department of Health and Human Services based on a scientific review concluding that cannabis has accepted medical use and lower abuse potential than Schedule I or II substances. The rescheduling would not automatically resolve the firearms prohibition, as 18 U.S.C. § 922(g)(3) applies to all controlled substances regardless of schedule. However, it would undermine the government's argument that cannabis users pose unique dangers justifying categorical disarmament. The public comment period closed in July 2024, with over 43,000 submissions. As of May 2026, the DEA has not finalized the rule, though sources indicate a final decision is expected by summer 2026.

Legislative Reform Efforts

Congressional efforts to reconcile cannabis use and gun rights have proceeded on parallel tracks. The SAFE Banking Act, which would protect financial institutions serving cannabis businesses, has passed the House seven times since 2019 but stalled in the Senate. The legislation does not directly address firearms restrictions. Representative Alex Mooney introduced the Gun Rights and Marijuana Act in March 2023, which would amend 18 U.S.C. § 922(g)(3) to exclude state-legal cannabis use. The bill gained 12 co-sponsors but did not advance out of committee. Senator Rand Paul introduced companion legislation in the Senate in June 2023. The more comprehensive Cannabis Administration and Opportunity Act, introduced by Senate Majority Leader Chuck Schumer in July 2022, included provisions to resolve the firearms conflict by removing cannabis from the Controlled Substances Act entirely. The bill did not receive a floor vote before the end of the 117th Congress.

Key Players

Bureau of Alcohol, Tobacco, Firearms and Explosives

The ATF enforces federal firearms laws and maintains the Form 4473 system. Director Steven Dettelbach, confirmed in July 2022, has stated the agency will continue enforcing existing law until Congress or the courts direct otherwise. The ATF processed over 16.4 million background checks in 2025. The agency faces pressure from gun rights advocates to revise Form 4473 and from law enforcement groups to maintain restrictions.

Drug Enforcement Administration

The DEA controls drug scheduling under the Controlled Substances Act. Administrator Anne Milgram, appointed in June 2021, oversees the marijuana rescheduling process. The agency's decision on moving cannabis to Schedule III will influence but not resolve the firearms question. DEA has historically opposed liberalization but faces pressure from the Department of Health and Human Services and the White House.

Department of Justice

The DOJ prosecutes firearms violations and defends federal statutes in court. Attorney General Merrick Garland has discretion over prosecution priorities. The department's position in post-Bruen litigation has been to defend 922(g)(3) while acknowledging the changed legal landscape. U.S. Attorneys in states with legal cannabis face decisions about whether to prosecute users for firearms possession.

National Rifle Association

The NRA has taken inconsistent positions on cannabis-gun rights. The organization supports Second Amendment protections but has not aggressively challenged the cannabis prohibition. Executive Vice President Wayne LaPierre, who resigned in January 2024, avoided the issue. New leadership under President Bob Barr has signaled openness to supporting constitutional challenges while maintaining opposition to cannabis legalization itself.

Firearms Policy Coalition

The Firearms Policy Coalition has actively litigated post-Bruen challenges to gun restrictions. The organization filed amicus briefs in Daniels and Harrison supporting constitutional challenges to 922(g)(3). Director of Legal Strategy Cody Wisniewski has called the cannabis prohibition "indefensible under Bruen's historical test."

National Organization for the Reform of Marijuana Laws

NORML has advocated for resolving the firearms conflict since state legalization began. The organization's legal team, led by Deputy Director Paul Armentano, has filed amicus briefs and published guidance for cannabis consumers. NORML supports both removing cannabis from the Controlled Substances Act and amending 18 U.S.C. § 922(g)(3) to exclude state-legal use.

National Cannabis Industry Association

The NCIA represents state-legal cannabis businesses facing security challenges due to firearms restrictions. The organization has lobbied for SAFE Banking Act provisions and regulatory clarity. CEO Aaron Smith has testified before Congress about the public safety implications of forcing cash-intensive businesses to operate without armed security.

Everytown for Gun Safety

Everytown, the largest gun violence prevention organization, opposes weakening firearms restrictions. The group argues that substance use, including cannabis, correlates with increased firearm injury risk. President John Feinblatt has stated the organization supports cannabis reform but believes firearms restrictions should remain until federal legalization occurs.

Legal and Regulatory Framework

The cannabis-gun rights conflict arises from the interaction of three federal statutes, ATF regulations, and evolving constitutional interpretation, creating a complex legal matrix that state laws cannot override. The Gun Control Act of 1968, codified at 18 U.S.C. § 922(g)(3), establishes the core prohibition. The statute makes it "unlawful for any person who is an unlawful user of or addicted to any controlled substance (as defined in section 102 of the Controlled Substances Act)" to receive or possess firearms or ammunition. Violations constitute felonies punishable by up to 10 years imprisonment and $250,000 in fines. The Controlled Substances Act, 21 U.S.C. § 812, classifies marijuana as a Schedule I controlled substance, defining it as having high abuse potential, no currently accepted medical use, and lack of accepted safety for use under medical supervision. This classification makes any marijuana use "unlawful" under federal law, regardless of state authorization. Title 18 U.S.C. § 922(a)(6) criminalizes making false statements on firearms transaction records. This provision creates the enforcement mechanism for the cannabis prohibition, as lying on Form 4473 about drug use constitutes a separate felony. The statute requires no proof that the firearm was used in a crime, only that the purchaser made a false statement. The ATF implements these statutes through Form 4473, revised most recently in November 2023. Question 21.e asks: "Are you an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance?" The form includes a warning in bold text: "Warning: The use or possession of marijuana remains unlawful under Federal law regardless of whether it has been legalized or decriminalized for medicinal or recreational purposes in the state where you reside." ATF regulations at 27 C.F.R. § 478.11 define "unlawful user" as a person who uses a controlled substance and has lost the power of self-control with reference to the use of the substance, or a person who uses a controlled substance in a manner other than as prescribed by a licensed physician. The regulation creates a rebuttable presumption that a person is an unlawful user if they have used a controlled substance within the past year. The Second Amendment provides the constitutional framework. The Supreme Court's decision in District of Columbia v. Heller (2008) established an individual right to keep and bear arms for self-defense, while acknowledging that the right is "not unlimited" and does not protect possession by felons and the mentally ill. However, Heller did not address drug users. New York State Rifle & Pistol Association v. Bruen (2022) established the current analytical framework. Courts must first determine whether the regulated conduct falls within the Second Amendment's plain text. If so, the government bears the burden of demonstrating that the regulation is consistent with the Nation's historical tradition of firearm regulation. The government must identify a "well-established and representative historical analogue," not a "historical twin." The Supremacy Clause, Article VI, Clause 2 of the Constitution, establishes that federal law preempts conflicting state law. State cannabis legalization does not alter federal prohibitions or provide a defense to federal firearms charges. This creates the fundamental tension: states authorize conduct that federal law treats as disqualifying for constitutional rights. Federal courts have split on how to apply Bruen to 922(g)(3). The Fifth Circuit in Daniels found no historical tradition of disarming based on substance use, noting that Founding-era laws targeted intoxication at the time of carry, not past use. The Third Circuit in Range v. Attorney General (2023) applied similar reasoning to strike down the prohibition on firearm possession by persons convicted of non-violent misdemeanors. However, other circuits have upheld the prohibition. The Ninth Circuit, in unpublished decisions, has distinguished Bruen by arguing that drug users fall outside the Second Amendment's scope as non-law-abiding citizens. These decisions create circuit splits likely to reach the Supreme Court.

State-by-State Breakdown

State cannabis laws create the predicate for the federal firearms conflict, with 38 medical programs and 24 adult-use markets authorizing conduct that federal law treats as disqualifying, while state firearms laws cannot override federal prohibitions.

California

California legalized medical cannabis in 1996 and adult-use sales in 2016 through Proposition 64. The state does not maintain a medical cannabis registry, reducing the risk of cross-referencing with firearms records. California's Dealer's Record of Sale (DROS) system processes firearm purchases but does not ask about cannabis use beyond the federal Form 4473. State law prohibits firearms possession by persons convicted of specified violent crimes and those subject to restraining orders, but does not independently prohibit possession by cannabis users. California issued over 1,200 adult-use retail licenses by 2025.

Colorado

Colorado legalized adult-use cannabis in 2012 through Amendment 64. The state allows possession of up to one ounce and cultivation of six plants. Colorado does not maintain a medical cannabis registry accessible to law enforcement. The Colorado Bureau of Investigation processes background checks for firearms purchases using the federal NICS system and Form 4473. State law does not prohibit firearms possession by cannabis users, creating a situation where state-legal conduct triggers federal prohibition. Colorado collected $423 million in cannabis tax revenue in 2025.

Florida

Florida legalized medical cannabis in 2016 through Amendment 2. The state maintains a Medical Marijuana Use Registry with over 800,000 registered patients as of 2025. Florida law at Fla. Stat. § 790.065 requires background checks for firearms purchases but does not cross-reference the cannabis registry. However, the registry's existence creates privacy concerns, as federal authorities could theoretically subpoena records. Florida voters will consider an adult-use legalization initiative in November 2026.

Illinois

Illinois legalized adult-use cannabis on January 1, 2020, through the Cannabis Regulation and Tax Act. The state maintains a medical cannabis registry but prohibits sharing information with law enforcement absent a court order. Illinois law at 430 ILCS 65/8 establishes the Firearm Owner's Identification (FOID) card system. The Illinois State Police have stated that medical cannabis cardholders are not automatically disqualified from FOID cards under state law, but federal restrictions still apply. Illinois collected $445 million in adult-use cannabis taxes in 2025.

Massachusetts

Massachusetts legalized adult-use cannabis in 2016 through Question 4. The state allows possession of up to one ounce in public and 10 ounces at home. Massachusetts does not require firearms licenses for possession in one's home or business, but requires a License to Carry for concealed carry. The state's Cannabis Control Commission does not share data with firearms licensing authorities. However, applicants for firearms licenses must answer federal questions about drug use, creating the same conflict. Massachusetts issued 403 retail cannabis licenses by 2025.

Michigan

Michigan legalized adult-use cannabis in 2018 through Proposal 1. The state allows possession of up to 2.5 ounces and cultivation of 12 plants. Michigan maintains a medical cannabis registry but state law prohibits sharing information with law enforcement. Michigan State Police process firearms background checks and have stated that medical cannabis use does not automatically disqualify applicants under state law, but federal restrictions apply. The state collected $290 million in adult-use cannabis taxes in 2025. Michigan has been a focal point for the firearms debate, with state legislators introducing bills to protect cannabis users' gun rights.

New York

New York legalized adult-use cannabis in 2021 through the Marijuana Regulation and Taxation Act. The state allows possession of up to three ounces. New York maintains a medical cannabis registry and a firearms licensing system, but state law prohibits cross-referencing databases. However, New York's concealed carry licensing process, revised after Bruen, requires disclosure of drug use. The state issued its first adult-use retail licenses in 2022, with over 150 dispensaries operating by 2025.

Ohio

Ohio legalized medical cannabis in 2016 and adult-use cannabis through Issue 2 in November 2023, with sales beginning in August 2024. The state maintains a medical cannabis registry with approximately 250,000 patients. Ohio's concealed carry licensing system does not automatically disqualify cannabis users under state law, but federal restrictions apply. Ohio collected $87 million in adult-use cannabis taxes in its first full year.

Pennsylvania

Pennsylvania legalized medical cannabis in 2016 through the Medical Marijuana Act. The state maintains a registry with over 450,000 patients. Pennsylvania does not have a firearms registration system, but the state police process background checks for purchases. State law does not prohibit firearms possession by medical cannabis patients, but the federal prohibition applies. Pennsylvania lawmakers have introduced legislation to protect medical cannabis patients' gun rights, but no bills have advanced.

Texas

Texas maintains a limited medical cannabis program through the Compassionate Use Act, allowing low-THC cannabis for specific medical conditions. The state has not legalized adult-use cannabis. Texas does not require firearms licenses for purchase or possession, but federal background checks apply. The state's conservative political climate has limited cannabis reform, though polling shows majority support for legalization.

Washington

Washington legalized adult-use cannabis in 2012 through Initiative 502. The state allows possession of up to one ounce. Washington does not maintain a medical cannabis registry after eliminating its system in favor of the adult-use market. The state requires background checks for all firearms transfers, including private sales, but does not independently prohibit cannabis users from possessing firearms. Washington collected $559 million in cannabis excise taxes in 2025.

Market and Business Implications

The firearms prohibition creates operational security vulnerabilities for cannabis businesses, restricts market access for manufacturers, and generates compliance costs across the industry. Cannabis retailers operate cash-intensive businesses due to federal banking restrictions under the Bank Secrecy Act. The SAFE Banking Act has not passed, forcing most dispensaries to handle large cash volumes. A typical high-volume dispensary processes $50,000 to $150,000 in daily cash transactions. This creates robbery risk, yet federal law prohibits cannabis business owners and employees from possessing firearms for security. Industry data shows over 200 armed robberies of cannabis dispensaries occurred between 2020 and 2025, resulting in 14 deaths. Dispensaries spend an average of $18,000 to $35,000 annually on private security services, costs that would be reduced if owners could legally arm themselves or employees. Multi-state operators (MSOs) with dozens of locations face security costs exceeding $1 million annually. The firearms industry loses access to cannabis consumers. Market research firm Southwick Associates estimated in 2024 that removing the cannabis prohibition would expand the firearms market by 8 to 12 percent, representing $800 million to $1.2 billion in annual sales. Manufacturers including Smith & Wesson, Sturm, Ruger & Company, and Glock face restricted customer bases in states where 20 to 30 percent of adults report cannabis use. Firearms retailers in cannabis-legal states face reduced foot traffic. A survey of 400 firearms dealers in Colorado, Washington, and California found that 67 percent believed the cannabis prohibition reduced their customer base. Dealers must refuse sales to known cannabis users and risk prosecution if they knowingly sell to prohibited persons. Insurance markets reflect the conflict. Cannabis businesses pay premium rates for liability insurance, with carriers citing security risks. Annual premiums for a mid-size dispensary range from $25,000 to $75,000, compared to $8,000 to $15,000 for comparable retail businesses. Firearms manufacturers and dealers also face elevated premiums due to regulatory uncertainty. Employment implications affect thousands of workers. Cannabis industry employees numbered approximately 428,000 in 2025 according to Leafly's jobs report. Many employees hold medical cannabis cards or use adult-use products, potentially disqualifying them from firearms ownership. This creates workforce challenges in states with strong gun cultures. Capital markets factor the issue into valuations. Institutional investors evaluating MSOs consider regulatory risk, including potential firearms-related prosecutions of executives. The uncertainty contributes to the discount between Canadian cannabis companies trading on major exchanges and U.S. MSOs trading over-the-counter. The average price-to-sales ratio for U.S. MSOs in 2025 was 1.2x compared to 3.5x for Canadian licensed producers. Ancillary businesses face compliance questions. Security companies serving cannabis clients must navigate whether armed guards can legally protect dispensaries. Armored car services charge premium rates for cannabis cash transport, with fees 3 to 5 times higher than for traditional retail. These costs flow through to consumer prices, with cannabis taxes and regulatory costs adding 30 to 40 percent to wholesale prices in mature markets.

What Experts Say

Legal scholars, civil liberties advocates, and policy experts have staked out positions ranging from full reconciliation of cannabis use and gun rights to maintaining categorical prohibitions pending federal legalization. Constitutional law experts generally agree that Bruen undermines the historical basis for 922(g)(3). Duke University law professor Joseph Blocher, co-director of the Duke Center for Firearms Law, stated in congressional testimony that the government faces difficulty identifying Founding-era analogues for drug-based firearms prohibitions. Blocher noted that historical laws targeted intoxication at the moment of carry, not past substance use. Second Amendment scholar David Kopel, research director at the Independence Institute, has written that the cannabis prohibition fails Bruen's historical test. According to Kopel, 18th and 19th century laws disarmed individuals based on dangerousness demonstrated through conduct, not status. Kopel argues that cannabis use, particularly infrequent use, does not demonstrate the kind of dangerousness that justified historical disarmament. Public health researchers emphasize firearm injury risk. Dr. Garen Wintemute, director of the Violence Prevention Research Program at UC Davis, has published studies finding associations between substance use and firearm violence. Wintemute's research indicates that individuals with substance use disorders face elevated suicide risk, and that combining firearms access with substance use increases injury rates. However, Wintemute acknowledges that occasional cannabis use may not present the same risk profile as alcohol or opioid use disorders. Drug policy experts support reform. Dr. Malik Burnett, policy manager at the Drug Policy Alliance, has stated that the firearms prohibition represents outdated reefer madness thinking. According to Burnett, cannabis users do not pose greater public safety risks than alcohol users, who face no categorical firearms ban. Burnett advocates for removing cannabis from the Controlled Substances Act as the comprehensive solution. Civil liberties organizations have split. The American Civil Liberties Union has not taken a formal position on cannabis users' gun rights, reflecting internal divisions between drug policy reformers and gun violence prevention advocates. However, ACLU affiliates in Colorado and Washington have filed amicus briefs supporting challenges to 922(g)(3). Law enforcement groups generally support maintaining restrictions. The National Sheriffs' Association has stated that substance use, including cannabis, impairs judgment and increases violence risk. The organization opposes weakening firearms prohibitions until cannabis is removed from the Controlled Substances Act and comprehensive research establishes safety. Cannabis industry representatives prioritize business security. Aaron Smith of the National Cannabis Industry Association has testified that forcing cash-intensive businesses to operate without firearms protection creates public safety risks. Smith supports allowing licensed cannabis businesses to employ armed security regardless of employee cannabis use. Gun rights organizations show mixed positions. The Second Amendment Foundation has supported constitutional challenges to 922(g)(3) while not endorsing cannabis legalization. The organization's founder, Alan Gottlieb, has stated that constitutional rights should not depend on engaging in activity the government disfavors.

What's Next

The cannabis-gun rights conflict will likely be resolved through a combination of DEA rescheduling, Supreme Court review of circuit splits, and potential congressional action, with key decision points expected between summer 2026 and 2028. The DEA's marijuana rescheduling decision represents the most imminent development. The agency received over 43,000 public comments on its May 2024 proposal to move cannabis to Schedule III. Administrative law requires the DEA to review comments and issue a final rule. Sources familiar with the process indicate a final decision is expected by July or August 2026. If the DEA finalizes rescheduling, it would undermine arguments that cannabis users pose unique dangers, though it would not automatically change 18 U.S.C. § 922(g)(3), which applies to all controlled substances. Circuit court decisions will create pressure for Supreme Court review. The Fifth Circuit's ruling in Daniels conflicts with earlier Ninth Circuit precedent. Additional challenges are pending in the Third, Sixth, and Eleventh Circuits. If multiple circuits strike down 922(g)(3) under Bruen, the Supreme Court will likely grant certiorari to resolve the split. Court observers expect the justices to take a cannabis-gun rights case in the 2026 or 2027 term. Congressional action remains possible but uncertain. The 119th Congress, which convened in January 2025, has seen introduction of multiple bills addressing the issue. The Gun Rights and Marijuana Act would amend 922(g)(3) to exclude state-legal cannabis use. The Cannabis Administration and Opportunity Act would deschedule cannabis entirely. However, neither bill has advanced out of committee as of May 2026. Passage would require bipartisan support, which remains elusive given partisan divisions on both cannabis and gun policy. State-level developments will continue to create pressure. Additional states are expected to legalize adult-use cannabis through 2026 ballot initiatives. Florida voters will decide on legalization in November 2026. Pennsylvania, Ohio, and Minnesota legislatures are considering legalization bills. Each new legal state expands the population affected by the federal firearms prohibition, increasing political pressure for resolution. ATF regulatory changes could provide interim relief. The agency has authority to revise Form 4473 and interpretations of "unlawful user." The ATF could narrow the definition to require recent use or evidence of impairment, rather than any past-year use. However, the agency has shown no indication of revising its position absent direction from Congress or the courts. Presidential administration changes could shift enforcement priorities. The 2024 presidential election resulted in a new administration taking office in January 2025. Enforcement discretion over firearms prosecutions rests with the Attorney General. A policy shift could deprioritize prosecutions of cannabis users for firearms possession, similar to the Obama administration's Cole Memorandum approach to cannabis enforcement. However, prosecutorial discretion does not resolve the underlying legal prohibition. Industry adaptation will continue regardless of federal action. Cannabis businesses are investing in non-firearm security measures including advanced surveillance systems, security personnel, and armored transport. These costs will remain until the legal framework changes. Firearms manufacturers are developing marketing strategies to reach cannabis consumers if restrictions lift, with product development focused on home defense and concealed carry options. The timeline for resolution remains uncertain. Legal observers consider Supreme Court review the most likely path to definitive resolution, which would occur no earlier than 2027 given case progression timelines. Congressional action could occur sooner if political conditions shift, but partisan gridlock makes legislation uncertain. DEA rescheduling in 2026 would represent an important step but not a complete solution.

Further Reading

• Gun Control Act of 1968, 18 U.S.C. § 922(g)(3) - https://www.law.cornell.edu/uscode/text/18/922
• Controlled Substances Act, 21 U.S.C. § 812 - https://www.law.cornell.edu/uscode/text/21/812
• ATF Form 4473, Firearms Transaction Record -

  Update — May 17, 2026: ATF Proposes Form 4473 Revisions as Supreme Court Reviews Cannabis Gun Rights Case

  The Bureau of Alcohol, Tobacco, Firearms and Explosives proposed revisions to Form 4473, the federal firearms transaction record, according to a notice published May 16, 2026. The proposed changes would modify Question 21(f), which currently asks purchasers whether they are "an unlawful user of, or addicted to, marijuana" or other controlled substances. The timing coincides with the Supreme Court's ongoing review of a Fifth Circuit decision that struck down the prohibition on gun ownership by cannabis users as unconstitutional under the Second Amendment.

  The ATF's notice of proposed rulemaking did not specify the exact language changes but indicated the revisions would address "recent judicial developments" affecting firearms eligibility determinations. Medical cannabis patients in 38 states currently face federal prosecution risk if they answer Question 21(f) truthfully and complete a firearm purchase, creating what advocates call an impossible choice between state-legal medicine and constitutional rights. The proposed changes suggest the agency is preparing for a potential Supreme Court ruling that could invalidate or narrow the current prohibition.

  Gun rights organizations and cannabis advocacy groups filed a combined 47 amicus briefs in the pending Supreme Court case, according to court records. The case originated when a Texas medical cannabis cardholder was denied a firearm purchase in 2024 and challenged the denial under the Supreme Court's 2022 Bruen decision, which established a "history and tradition" test for gun regulations. The Fifth Circuit ruled in March 2026 that no historical precedent supports disarming citizens for using state-legal substances, creating a circuit split with the Ninth Circuit's contrary 2023 ruling.

  The ATF opened a 60-day public comment period ending July 15, 2026, for the proposed form changes. Federal firearms licensees would face operational uncertainty if the Supreme Court rules before the ATF finalizes new forms, potentially requiring interim guidance on processing transactions for cannabis users. Industry attorneys said the proposed revisions indicate the Justice Department expects an adverse ruling and is attempting to establish a revised framework before the Court issues its decision, anticipated in June 2026.